Streetbeat News

Products Services

APLS

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced that The Lancet published positive 24-month results from Phase 3 studies of SYFOVRE for geographic atrophy (GA). SYFOVRE demonstrated clinically meaningful reductions in GA lesion growth and is the only treatment approved for use beyond 12 months for GA. The company has five additional applications under review globally.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:35 pm

DERM

Journey Medical Corporation (NASDAQ:DERM) announced data from a comparative bioavailability study of DFD-29 vs. Solodyn. The study demonstrated that the systemic exposure of DFD-29 was significantly lower than that of Solodyn. The company plans to submit a New Drug Application to the FDA for DFD-29 in the fourth quarter of 2023. DFD-29 is being developed for the treatment of rosacea in collaboration with Dr. Reddy's Laboratories Ltd.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:33 pm

ALLG

Allego has partnered with Go'on to expand electric vehicle charging accessibility in Denmark. The partnership will result in 168 charging ports across Go'on's 185 locations. The first seven stations are expected to be commissioned between Q4 2023 and Q2 2024, with 60 additional stations planned through Q4 2024. Allego will have exclusive access to all of Go'on's stations to expand its ultra-fast charging network.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:31 pm

LI

SDA

SunCar Technology Group Inc. (NASDAQ:SDA) has launched an online insurance solution for customers of Li Auto Inc.'s (NASDAQ:LI) new energy vehicles (NEV). The insurance solution is accessible via the Li Auto car owners' app. SunCar's CEO believes this cooperation with Li Auto will expand their customer base and provide a new avenue for growth. SunCar already has the largest market share for after-sales services in the NEV space in China. Li Auto is a leader in China's NEV market.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:31 pm

AMZN

CAJFF

Amazon.com Inc. (NASDAQ:AMZN) founder Jeff Bezos' old product reviews on Amazon have gone viral on social media. The reviews include those of Tuscan dairy milk and Canon Inc. (OTCPK: CAJFF) binoculars. Bezos' reviews provide insight into his personal preferences and his understanding of technology, as seen in his review of Canon's image-stabilizing binoculars.

Portfolio Pulse from Rounak Jain

October 20, 2023 | 12:15 pm

MRK

Merck has announced that its drug KEYTRUDA, in combination with chemotherapy, has shown statistically significant improvement in pCR rate as neoadjuvant therapy versus chemotherapy alone in high-risk, early-stage ER+/HER2- breast cancer.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:08 pm

MRK

Merck has announced that its drug KEYTRUDA, in combination with trastuzumab and chemotherapy, has significantly improved progression-free survival in first-line HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma patients, compared to trastuzumab and chemotherapy alone.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:07 pm

MRK

Merck has reported results from the Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA, its Anti-PD-1 therapy, as a perioperative treatment regimen for NSCLC patients.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:04 pm

ARQT

New data from the DERMIS trials shows that 95% of individuals treated with ZORYVE Cream 0.3% had a measurable improvement in Psoriasis Area and Severity Index (PASI) at Week 8. Over 85% achieved measurable improvement by Week 2. The data also confirms that ZORYVE is well tolerated according to both investigator and patient local tolerability assessments.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:04 pm

KBH

KB Home has announced the grand opening of two new communities in the Southtown Master Plan in Vacaville, California. This expansion is expected to boost the company's presence in the region.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:01 pm